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Testicular sperm retrieval techniques associated with intracytoplasmic sperm injection have changed the field of
male infertility treatment and given many azoospermic men the chance to become biological fathers. Despite
the current use of testicular sperm extraction, reliable clinical and laboratory prognostic factors of sperm
recovery are still absent. The objective of this article was to review the prognostic factors and clinical use of
sperm retrieval for men with non-obstructive azoospermia.
The PubMed database was searched for the Medical Subject Headings (MeSH) terms azoospermia, sperm
retrieval, and prognosis. Papers on obstructive azoospermia were excluded. The authors selected articles that
reported successful sperm retrieval techniques involving clinical, laboratory, or parenchyma processing
methods. The selected papers were reviewed, and the prognostic factors were discussed.
No reliable positive prognostic factors guarantee sperm recovery for patients with non-obstructive
azoospermia. The only negative prognostic factor is the presence of AZFa and AZFb microdeletions.
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& INTRODUCTION
In the last 20 years, the most important development in
male factor infertility has been the introduction of intracy-
toplasmic sperm injection (ICSI). ICSI brought hope for men
with severe male factor infertility who wanted to become
biological fathers.
Since Devroye et al.’s (1) report on the use of testicular
spermatozoa in an azoospermic male to fertilize human
oocytes, physicians have sought a safe and simple method
of testicular sperm extraction that is associated with a high
recovery rate. Ideally, the best method would only cause
minor testicular damage, present a high recovery rate, have
a low cost and be reproducible. The first proposed
technique was named testicular sperm extraction (TESE)
and was simply a testicular biopsy. Further discussions
about this technique involved the number of testicular
fragments taken, the site of the extraction and in the last
decade, the use of microsurgery to improve the results (2).
Despite the current use of testicular sperm extraction,
reliable clinical and laboratory prognostic factors of sperm
recovery are missing. Prognostic factors have included testis
size, follicle stimulating hormone (FSH), inhibin beta, the
etiology of infertility, and genetic alterations; however, the
histological testicular pattern remains the best predictor of
sperm retrieval, although with the inconvenience of a
second invasive procedure (3).
The objective of this article was to review the prognostic
factors and clinical use of sperm retrieval for men with non-
obstructive azoospermia.
& METHODS
The PubMed database was searched for the Medical
Subject Headings (MeSH) terms azoospermia, sperm retrie-
val, and prognosis. Papers on obstructive azoospermia were
excluded. The authors selected articles that reported
successful clinical, laboratory, or parenchyma processing
methods. The selected papers were reviewed, and the
prognostic factors were discussed.
Spermatogenesis is a complex process that involves a
mitotic and meiotic cellular division and depends on more
than 40 enzymes. While the process occurs in the testicle,
part of the process is completely isolated from the
immunological system that is hidden behind the blood-
testicular barrier (4). Non-obstructive azoospermia is the
most serious alteration of the spermatogenesis, and its
evaluation and treatment remain a challenge. Although
there are well-established treatment protocols, the chances
of successful clinical or surgical treatment for non-obstruc-
tive azoospermia are small. For most patients, the remaining
option is based on sperm retrieval and ICSI.
Sperm retrieval is conducted with testicular aspiration or
biopsy for testicular sperm extraction (TESE), and laboratory
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searches are conducted for viable sperm that can be used for
ICSI. TESE is an invasive procedure and should be done with
the intention of treatment. Sperm retrieval procedures are
associatedwith uncertainties, high costs and the possibility of
morbidity for women who suffer from ovarian hyper
stimulation during the oocytes retrieval procedure. The
prognostic factors of sperm retrieval are important to
understand.
Historical prognostic factors for sperm recovery in non-
obstructive azoospermia are related to the clinical, labora-
tory, and surgical technique; the testicular tissue processing
method in the gamete laboratory; and the histological
pattern of the testis.
& CLINICAL
Clinical aspects related to sperm recovery include the
etiology of infertility and the age and testicular volume of the
patient. For non-obstructive azoospermia, these three prog-
nostic factors are typically considered alone or combined
with endocrinologic data. For the etiology of azoospermia,
there are data on Klinefelter syndrome, cryptorchidism, and
varicocele.
Klinefelter syndrome is a karyotype alteration that results
from a supernumerary X chromosome that can be expressed
in two forms: mosaic and non-mosaic. Klinefelter syndrome
is usually associated with infertility. The sperm recovery
rate in Klinefelter patients is approximately 50% (5-7).
Previous literature suggests that age (5) and testicular
volume (4) are prognostic factors, but a more recent study
showed no correlation between clinical parameters and
sperm retrieval (7). However, these studies used limited
numbers of patients, ranging from 20 to 51. In 2010, a review
of 13 papers involving 373 Klinefelter patients with
azoospermia who underwent sperm retrieval showed that
clinical parameters were not good prognostic factors (8).
Cryptorchidism is one of the most common child mal-
formations, and it affects 3% of full term male infants.
Cryptorchidism is related to male infertility, testicular
tumors, testicular torsion, and inguinal hernias (9). Studies
on the clinical factors related to sperm retrieval in
cryptorchid patients have small numbers of individuals,
and the conclusions remain controversial. Negri et al. (10)
compared 30 azoospermic cryptorchid men with 77 men
with various causes of non-obstructive azoospermia and
concluded that bilateral orchidopexy was a positive pre-
dictive factor for sperm finding after TESE. However, the
authors did not compare unilateral and bilateral orchido-
pexy, which invalidates the final conclusion. In a study of 38
azoospermic men who had previously undergone surgical
treatment for cryptochidism, Raman and Schlegel (11)
found correlations between sperm recovery rate and age
at orchidopexy and testicular volume. Men who had had
surgery before they were ten years old had a better sperm
recovery rate than men who had had orchidopexy at ten
years of age or higher. More recently, Wiser et al. (12)
studied 40 patients who had undergone orchidopexy and
were presenting with azoospermia and found no statisti-
cally significant differences between men who had under-
gone surgery before or after ten years of age. The authors
also found no significant relationship between sperm
recovery rate and testicular volume.
Varicocele is an important male infertility factor that has a
high incidence. While surgical treatment is possible, the
discussion about surgical treatment and in vitro fertilization
(IVF) remains active in the literature. The benefits of
treatment in terms of sperm quality are difficult to question,
but the issue becomes complicated for patients with
azoospermia associated with varicocele who want to
naturally conceive after surgical correction (13,14). Lee
et al. (14) analyzed the cost effectiveness of live birth after
varicocele treatment for patients with azoospermia after
testicular microdissection and ICSI. The authors concluded
that ICSI was the most cost effective. The goal of the present
article was to discuss whether varicocele treatment before
TESE improves the chances of retrieving sperm and serves
as a positive prognostic factor. Inci et al. retrospectively
studied 96 patients with varicocele and non-obstructive
azoospermia. Sixty-six patients had undergone a previous
surgical varicocele treatment with TESE or ICSI at least five
months previously, and 30 patients had not previously
undergone treatment. The mean patient ages, testicular
volumes, FSH levels, and partner ages were not significantly
different between the two groups. The results showed a
significantly better recovery rate for the treated group (53%
versus 30%). There were no statistically significant differ-
ences in embryo quality, implantation rates, miscarriage
rates, or live birth rates (15).
& LABORATORY
Laboratory investigations are based on tests that verify
the hypothalamic-pituitary-gonadal axis by measuring
follicle-stimulating hormone (FSH) levels and the feedback
regulator inhibin B. Other tests include the genetic detection
of chromosome alterations.
An intact hypothalamic-pituitary-gonadal axis is neces-
sary for correct sperm production. The FSH level was
initially used as a predictor of sperm recovery, but its use
remains controversial. Ramasamy et al. evaluated 792 men
with non-obstructive azoospermia who underwent testicu-
lar microdissection. The men were divided into four groups
according to FSH levels: less than 15 IU/mL, between 15
and 30 IU/mL, 31 to 45 IU/mL, and greater than 45 IU/mL.
Compared with the group with less than 15 IU/mL FSH,
the recovery rate for mature sperm was significantly higher
in the groups with greater than 15 IU/mL FSH (16). Chen et
al. conducted a prospective study with 208 patients who
underwent an FSH test and TESA. To establish an FSH cut-
off limit, the men were divided into two groups based on
mature sperm recovery. The authors found a cut-off value of
19.4 mIU/mL. Sperm was not found in men with FSH levels
at or above the cut-off limit (17). Both of these studies have a
large number of patients and had the prime objective of
analyzing the relationship between FSH levels and sperm
finding; in the second study, the mean FSH levels for
successful sperm recovery were in the normal range and did
not characterize the histological findings in each group. A
predominance of hypospermatogenesis in the successful
group may explain the findings.
Inhibins, anti-Mullerian hormone (AMH), and activins
are glycoproteins that are transforming growth factors
(TGF). These glycoproteins cause the pituitary gland to take
part in the feedback mechanism at the hypothalamic-
pituitary-gonadal axis. For this reason, they can be used as
spermatogenesis markers. Plasma levels of inhibin fraction
B and seminal levels of AMH can be used as predictive
parameters for sperm recovery in non-obstructive azoospermia
Sperm Retrieval in NOA
Glina S and Vieira M
CLINICS 2013;68(S1):121-124
122
(18). Inibine B and AHM can be measured in the plasma or
seminal plasma, and their clinical use is debated in the
literature (19). A prospective study of 139 men with non-
obstructive azoospermiawas conducted byMitchell et al. The
authors measured FSH, inhibin B in the plasma and AMH in
the seminal plasma before TESE, and they compared the
mean levels of successful sperm retrieval with the failed
group. The recovery sperm rate was 43% (60/139), and there
was a statistically significant correlation between serum and
seminal plasma inhibin B levels and seminal plasma AMH
and inhibin B levels. However, the mean inhibin B seminal
plasma levels and mean AMH seminal plasma levels did not
show statistically significant differences between the success-
ful and failed sperm retrieval groups. On the contrary, the
mean serum levels of FSH and serum inhibin B differed
between the two groups; the statistical significance is difficult
to explain and justify (19).
Tiepolo and Zuffardi postulated the involvement of
deletions in the long arm of the Y chromosome. Using a
cytogenetic analysis, they identified a region known as
azoospermia factor (AZF). That region was later subdivided
into three regions (AZFa, AZFb, and AZFc), and the
relationship with infertility was established. Y chromosome
microdeletions occur in 6-8% of severely oligozoospermic
men and 3-15% of azoospermic men. The importance of Y
microdeletions as a prognostic factor for sperm recovery is
based on the absence of mature sperm in azoospermic men
with AZFa and AZFb microdeletions who underwent sperm
retrieval techniques. Fortunately, AZFc is the Y microdele-
tion most often found in azoospermic men (60%), and sperm
can be retrieved for these patients. For this reason, the
presence of AZFa or AZFb is a negative predictive factor for
sperm retrieval in azoospermic men (20).
& SURGICAL TECHNIQUES
To analyze the surgical technique as a prognostic factor, it
is necessary to compare existing techniques. Sperm can be
retrieved from testicles using percutaneous (testicular
sperm aspiration, TESA; testicular fine needle aspiration,
TFNA) or open (testicular sperm extraction, TESE; testicular
microdissection, TM) methods (21). Comparisons between
these techniques are difficult, as patients are not the same,
and the efficacy of the method varies according to the
testicular histology. Percutaneous methods are less invasive,
but the laboratory has less tissue to search for sperm. Open
techniques provide larger samples to work with but are
more invasive. Finally, TFNA mapping attempts to combine
the qualities of the anterior techniques by mapping the
parenchyma and making a target opening, but an expert
cytologist is still required to correctly identify mature sperm
on the cytology sample. In general, percutaneous techniques
are more successful in hypospermatogenesis than in other
histological patterns (21). The sperm recovery rates range
from 11-47% for TESA, 30-63% for TESE, and 43-63% for
TM; the rate for TFNA is approximately 47% (21).
Since Schlegel’s 1999 publication of the TM technique (2),
studies have attempted to find its superiority over previous
methods, but definitive conclusions are difficult to make.
The comparative studies that found statistically significant
differences between TESE and TM used different testicles
(22), took one to three TESE samples per testicle (22,23) or
did not explore two testicles in the previous TESE (24).
In 2000, Amer et al. compared classic biopsy on one side
and testicular microdissection on the other, in 116 non-
obstructive azoospermic men. The study aimed to verify
the sperm retrieval rates and parenchymal changes in the
Doppler ultrasound during the first six months after the
procedure. The sperm retrieval rate was significantly
higher on the side that underwent testicular microdissec-
tion, and at the end of the follow-up, there were no
permanent devascularization areas in the testes. Biopsies
were performed on the same patients. Authors used 100
patients with similar histology for comparison, however,
only one testicular fragment was retrieved in classic biopsy
side and evaluated (22).
In a retrospective comparative study, Okada et al. analyzed
two groups of patients with obstructive and non-obstructive
azoospermia who had undergone TESE and testicular
microdissection. The authors reported a better sperm
retrieval rate with testicular microdissection. This advantage
was present for all patterns of testicular histology; however,
TESE was performed using three 5-mm incisions (23).
In a retrospective study with 46 patients who had
undergone traditional TESE and whose sperm retrievals
had failed, Tsujimura et al. found a 44% sperm retrieval rate
with testicular microdissection and concluded that the
technique was superior. When analyzing the results, the
authors highlighted the difference between the sperm
retrieval rates in patients with one (47%) or three (33%)
testicular fragments; only nine patients had multiple
bilateral fragments collected in the first TESE procedure,
which suggests that the amount of tissue removed should be
considered (24).
In 2002, Tsujimura et al. compared several conventional
TESE and testicular microdissection techniques in different
patients and found no significant differences in the sperm
retrieval rates between the groups (25).
& TESTICULAR TISSUE PROCESSING METHOD
After tissue has been removed, two methods can be used
to open the seminiferous tubules to separate the structural
tissue from the viable sperm: enzymatic tissue digestion and
mechanical tissue disruption.
Mechanical preparation consists of using needles or
scalps to mince and shred the tissue to open the tubules
and separate the sperm from the tubular epithelium. The
procedure is conducted in the operating room at the same
time as the surgery and later in the manipulation laboratory,
and the procedure is typically associated with a micro-
droplets search for viable spermatozoa (26). Enzymatic
preparation uses a collagenase tissue exposure to liberate
sperm from the tubules so that they can be manipulated
in the laboratory (26). A comparison between the two
techniques was conducted by a multicenter German study.
The data were from eleven centers that used testicular
sperm from obstructive and non-obstructive azoospermia,
but the authors did not conduct separate analyses of the
techniques; thus, the results are inconclusive (26).
Enzymatic tissue digestion can be used in the laboratory
after a mechanical preparation is conducted to rescue
negative initial searches by digesting the testicular parench-
yma and freeing sperm. A study of 501 negative testicular
samples from testicular microdissection showed that an
enzymatic preparation could rescue sperm in seven percent
of men after a mechanical preparation (27).
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& HISTOLOGIC PATTERN
The most reliable factor for predicting sperm retrieval in
non-obstructive azoospermic patients is the testicular
histological pattern. However, its use is limited, as the
patient must undergo a prognostic biopsy, which adds a
surgical procedure. The worst pattern for sperm recovery is
Sertoly cell-only syndrome, which has a rate of sperm
retrieval ranging from 4-51%; maturation arrest (8-80%) is
affects sperm recovery adversely, while hypospermatogen-
esis produces high rates of sperm recovery (80-100%)
(3,28,29).
Non-obstructive azoospermia remains the most challen-
ging diagnosis for andrologists, and there are no positive
prognostic factors that guarantee sperm recovery for these
patients. The only reliably negative prognostic factor is the
presence of AZFa and AZFb microdeletions.
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